Skip to main navigation Skip to search Skip to main content

Mechanistic insights into LDL nanoparticle-mediated siRNA delivery

  • Honglin Jin
  • , Jonathan F. Lovell
  • , Juan Chen
  • , Qiaoya Lin
  • , Lili Ding
  • , Kenneth K. Ng
  • , Rajendra K. Pandey
  • , Muthiah Manoharan
  • , Zhihong Zhang
  • , Gang Zheng
  • Huazhong University of Science and Technology
  • University Health Network
  • University of Toronto
  • Alnylam Pharmaceuticals

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Abstract

Although small interfering RNA (siRNA) can silence the expression of disease-related genes, delivery of these highly charged molecules is challenging. Delivery approaches for siRNAs are actively being pursued, and improved strategies are required for nontoxic and efficient delivery for gene knockdown. Low density lipoprotein (LDL) is a natural and endogenous nanoparticle that has a rich history as a delivery vehicle. Here, we examine purified LDL nanoparticles as carriers for siRNAs. When siRNA was covalently conjugated to cholesterol, over 25 chol-siRNA could be incorporated onto each LDL without changing nanoparticle morphology. The resulting LDL-chol-siRNA nanoparticles were selectively taken up into cells via LDL receptor mediated endocytosis, resulting in enhanced gene silencing compared to free chol-siRNA (38% gene knock down versus 0% knock down at 100 nM). However, silencing efficiency was limited by the receptor-mediated entrapment of the LDL-chol-siRNA nanoparticles in endolysosomes. Photochemical internalization demonstrated that endolysosome disruption strategies significantly enhance LDL-mediated gene silencing (78% at 100 nM).

Original languageEnglish
Pages (from-to)33-41
Number of pages9
JournalBioconjugate Chemistry
Volume23
Issue number1
DOIs
StatePublished - Jan 18 2012

Fingerprint

Dive into the research topics of 'Mechanistic insights into LDL nanoparticle-mediated siRNA delivery'. Together they form a unique fingerprint.

Cite this